Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Early Colostomy Reversal May Improve Outcomes

By HospiMedica International staff writers
Posted on 17 Dec 2018
A new study suggests that in selected patients, colostomy closure following the Hartmann procedure for diverticulitis is safe as early as 45 days after the initial procedure.

Researchers at Yale School of Medicine (New Haven, CT, USA) conducted a retrospective analysis of inpatient databases for California, Florida, and Maryland in order to explore the association between colostomy reversal timing and operative outcomes in 1,660 patients (51.8% men, median age 61 years) who underwent the Hartmann procedure for diverticulitis. More...
The patients were divided based on timing of colostomy reversal following the index surgery into early (45-110 days), middle (111-169 days), and late (≥170 days). Patients with readmissions between the index surgery and reversal were excluded.

The results revealed that the median time to reversal was 129 days. Patient characteristics associated with early reversal included being 60 years or younger, white, and having private insurance (compared to Medicaid). Mortality, transfusion, presence of ileus, and major complications were not significantly different among groups. However, prolonged length of stay and 90-day readmission was significantly more likely in the late timing groups. The study was published on November 21, 2018, in JAMA Surgery.

“Less than one-third of patients undergo colostomy reversal within one year after end colostomy for diverticulitis, and reversal timing is associated with socioeconomic disparities,” concluded senior author Kevin Pei, MD, and colleagues. “In selected patients with an uncomplicated course, improved outcomes are associated with earlier reversal, and colostomy reversal is safe as early as 45 to 110 days after the initial procedure.”

Hartmann's procedure, or proctosigmoidectomy, involves surgical resection of the rectosigmoid colon with closure of the anorectal stump and formation of a colostomy. It is the most common operation carried out by general surgeons for management of malignant obstruction of the distal colon. During the procedure, the lesion is removed, the distal bowel closed intraperitoneally, and the proximal bowel diverted with a stoma. The procedure is named after French surgeon Henri Albert Hartmann, who first described it in 1921.

Related Links:
Yale School of Medicine


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.